[Treatment of dysentery in children with a combination of monomycin and Eleutherococcus].
An acute dysentery process was studied in 100 children at the age of 1 to 14 years treated with monomycin; 54 patients (the 1st group) were treated with monomycin in combination with eleuterococcus and 46 patients (the 2nd group) were treated with monomycin alone. The dysentery process in the both groups was close. However, the increase in the levels of gamma-globulin, antidysentery antibodies and the phases of changes in the index of phagocytosis completeness during the disease were more pronounced in the patients of the 2nd group than those in the children of the 1st group. Recovery of the patients of the 1st group was registered earlier. It was concluded that eleuterococcus as an adaptagen provided recovery of the patients at lower efforts of the protection mechanisms. Wide use of eleuterococcus in combination with monomycin for the treatment of children with dysentery is recommended.
D000208:Acute Disease; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D015643:Erythromycin Ethylsuccinate / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D010936:Plant Extracts / Q000627:therapeutic use*
D004338:Drug Combinations; D010936:Plant Extracts; D015643:Erythromycin Ethylsuccinate
Lechenie dizenterii u deteĭ sochetaniem monomitsina s éleuterokokkom.